Top compounds associated with response to SLC2A13

Feature Type	Compound	Dataset	Tissue	Stat	Standardized Coefficient	Nominal ANOVA p-value
mRNA	CID-5951923	CTRPv2	pan-cancer	AAC	0.0087	0.8
mRNA	Vorinostat	CTRPv2	pan-cancer	AAC	0.0075	0.8
mRNA	nintedanib	CTRPv2	pan-cancer	AAC	-0.0084	0.8
mRNA	VX-680	GDSC1000	pan-cancer	AAC	-0.012	0.8
mRNA	tivozanib	GDSC1000	pan-cancer	AAC	-0.0076	0.8
mRNA	Tamoxifen	GDSC1000	pan-cancer	AAC	-0.0075	0.8
mRNA	JW-7-24-1	GDSC1000	pan-cancer	AAC	-0.0065	0.8
mRNA	tanespimycin:bortezomib (250:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.0082	0.8
mRNA	UNC0638:navitoclax (1:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.008	0.8
mRNA	LFM-A13	GDSC1000	pan-cancer	AAC	-0.0076	0.8

Download CSV